Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys
Yes, GW Pharmaceuticals (NASDAQ: GWPH) is the biggest marijuana-focused biotech stock on the market. The company's promising cannabinoid Epidiolex could very well become a blockbuster success story in the near future in treating children with rare forms of epilepsy. But is GW Pharmaceuticals the best stock to buy right now? No.
Two stocks that could have significantly greater upside, in my view, are Vertex Pharmaceuticals (NASDAQ: VRTX) and Zynerba Pharmaceuticals (NASDAQ: ZYNE). Here's why investors might want to forget about GW Pharmaceuticals and instead buy Vertex and Zynerba.
Image source: Getty Images.
Source: Fool.com
Vertex Pharmaceuticals Inc. Aktie
422,25 €
-0,05 %
Die Vertex Pharmaceuticals Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Ein Kursziel von 440 € für Vertex Pharmaceuticals Inc. zeigt ein leicht positives Potenzial im Vergleich zum aktuellen Kurs von 422.25 €.
